An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer - Concepedia

Concepedia

Publication | Open Access

An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer

DOI Full Paper Access

63

Citations

0

References

2014

Year

Rocio García‐Carbonero, Fernando Rivera, Joan Maurel, Jean-Pierre M. Ayoub, Malcolm J. Moore, Andrés Cervantes, Timothy R. Asmis, Jonathan D. Schwartz, Federico Nasroulah, Shaila Ballal,

Abstract

RAM may enhance the efficacy of modified FOLFOX-6 chemotherapy with an acceptable safety profile in metastatic CRC.